Roar for rare (diseases)
Roar for rare (diseases)
Fighting against rare diseases together
Diseases that are rare, need much more care
Rare diseases are serious, chronic, debilitating and life-threatening diseases that require long-term and specilized management. These rare diseases disproportionately impact children, often resulting in some form of handicap, which can sometime be extremely severe. Given their rarity, these conditions are difficult to dignose and treat. Patients end up enduring a long journey involving specialty doctors, tests and misdiagnoses.
7% of Indians live with a rare disease1, yet 43% of healthcare professionals have never encountered even one2. Rare diseases are not rare in aggregate, but their individual complexity means they are routinely missed or misdiagnosed, resulting in delays and irreversible damage.
AccelRare® changes this equation. This AI-powered digital pre-diagnosis tool is designed to transform the way healthcare professionals (HCPs) diagnose rare diseases.
In just 5-10mins, an HCP can enter a patient’s symptoms, medical history, and test results into the free, highly secure, anonymous, web-based platform and receive a differential diagnosis covering 310 rare diseases, with a reliability rate above 88. The tool provides a complete description of each suspected disease, recommends complementary diagnostic exams, and maps the patient to relevant government-recognized Centres of Excellence across India for immediate referral.
If you're an HCP suspecting a possible diagnosis, click here to access the AccelRare® platform: https://www.accelrare.fr/
Around 7,000 rare diseases exist impacting ~300 million people worldwide3
The Organization for Rare Diseases India (ORDI) has currently listed 264 rare diseases in India, while an approximate figure of around 70 million individuals in the Indian population can be estimated to be living with such rare disorders.4
Rare diseases do not discriminate; they affect people from all walks of life and in all economic circumstances.
In support of people with rare diseases: Indian Charitable Access Program
For patients with rare diseases, we are committed to not only develop effective therapies but also ensure that these therapies reach them.
Since 1999, Sanofi's India Charitable Access Program (InCAP) has provided support to more than 100 patients in the country and continue to do so. The program is guided by an expert medical committee that remains closely involved in participating patients' care and progress.
25-years of Sanofi's presence for Rare Diseases in India
Our rare diseases business focuses on these uncommon and underserved medical conditions. We are committed to empowering the lives of patients with rare diseases by offering sustainable and transformative healthcare options.
Free Diagnostic Support
Since 2013, Sanofi has been offering diagnostic support for 5 Lysosomal Storage Disorders (LSDs) – Gaucher disease, Fabry disease, Pompe disease, MPS I, and ASMD. Over the last decade, we have enabled more than 10,000 tests under our diagnostic program.
Centres of Excellence
Centres of Excellence across India under National Policy on Rare Diseases (NPRD)5
References
- Taneja A, Shashidhara LS, Bhattacharya A. Rare diseases in India: Time for cure-driven policy initiatives and action. Curr Sci. 2020;118(10):1500-1506.
- Rao K. India steps forward as a global leader in rare disease management. RareDiseases.in. Accessed January 19, 2026. https://www.rarediseases.in/india-steps-forward-as-a-global-leader-in-rare-disease-management/
- The Lancelet Global Health, Vol 12 March 24
- J Biosci (2024) 49:28
- https://rarediseases.mohfw.gov.in
MAT-IN-2501046-1.0-09/2025